These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27051513)

  • 1. A physiome interoperability roadmap for personalized drug development.
    Thomas S; Wolstencroft K; de Bono B; Hunter PJ
    Interface Focus; 2016 Apr; 6(2):20150094. PubMed ID: 27051513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating knowledge representation and quantitative modelling in physiology.
    de Bono B; Hunter P
    Biotechnol J; 2012 Aug; 7(8):958-72. PubMed ID: 22887885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modular modelling with Physiome standards.
    Cooling MT; Nickerson DP; Nielsen PM; Hunter PJ
    J Physiol; 2016 Dec; 594(23):6817-6831. PubMed ID: 27353233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is personalized medicine a dream or a reality?
    Morse BL; Kim RB
    Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Databases for multilevel biophysiology research available at Physiome.jp.
    Asai Y; Abe T; Li L; Oka H; Nomura T; Kitano H
    Front Physiol; 2015; 6():251. PubMed ID: 26441671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.
    Kantae V; Krekels EHJ; Esdonk MJV; Lindenburg P; Harms AC; Knibbe CAJ; Van der Graaf PH; Hankemeier T
    Metabolomics; 2017; 13(1):9. PubMed ID: 28058041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable.
    Nickerson D; Atalag K; de Bono B; Geiger J; Goble C; Hollmann S; Lonien J; Müller W; Regierer B; Stanford NJ; Golebiewski M; Hunter P
    Interface Focus; 2016 Apr; 6(2):20150103. PubMed ID: 27051515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
    Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
    Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty and variability in computational and mathematical models of cardiac physiology.
    Mirams GR; Pathmanathan P; Gray RA; Challenor P; Clayton RH
    J Physiol; 2016 Dec; 594(23):6833-6847. PubMed ID: 26990229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in oral personalized medicine: contribution of 'omics'.
    Glurich I; Acharya A; Brilliant MH; Shukla SK
    J Oral Microbiol; 2015; 7():28223. PubMed ID: 26344171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.
    Gieschke R; Steimer JL
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):49-58. PubMed ID: 11032091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The IUPS Physiome Project: a framework for computational physiology.
    Hunter PJ
    Prog Biophys Mol Biol; 2004; 85(2-3):551-69. PubMed ID: 15142761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
    Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
    Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.
    Hartmanshenn C; Scherholz M; Androulakis IP
    J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):481-504. PubMed ID: 27647273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice.
    Vizirianakis IS
    Curr Drug Deliv; 2004 Jan; 1(1):73-80. PubMed ID: 16305372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a VPH/Physiome ToolKit.
    Garny A; Cooper J; Hunter PJ
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(2):134-147. PubMed ID: 20836018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of drug discovery for personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IUPS human Physiome Project.
    Hunter P; Robbins P; Noble D
    Pflugers Arch; 2002 Oct; 445(1):1-9. PubMed ID: 12397380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry.
    Amare AT; Schubert KO; Baune BT
    EPMA J; 2017 Sep; 8(3):211-227. PubMed ID: 29021832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ayurnutrigenomics: Ayurveda-inspired personalized nutrition from inception to evidence.
    Banerjee S; Debnath P; Debnath PK
    J Tradit Complement Med; 2015 Oct; 5(4):228-33. PubMed ID: 26587393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.